Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Sep 15;10(18):2735-9.
doi: 10.3748/wjg.v10.i18.2735.

ADAM17 mRNA expression and pathological features of hepatocellular carcinoma

Xiang Ding  1 , Lian-Yue Yang, Gen-Wen Huang, Wei Wang, Wei-Qun Lu
Affiliations

ADAM17 mRNA expression and pathological features of hepatocellular carcinoma

Xiang Ding et al. World J Gastroenterol. .

Abstract

Aim: To study the expression of a disintegrin and metalloproteinase 17 (ADAM17) mRNA in hepatocellular carcinoma (HCC) and to evaluate the relationship between ADAM17 mRNA expression and clinicopathological features of HCC.

Methods: Hepatocellular carcinomas (HCC) from 31 cases were divided into small HCC (SHCC), nodular HCC (NHCC) and solitary large HCC (SLHCC) according to tumor diameter and the number of nodes. ADAM17 mRNA expressions were compared among those groups by means of semi-quantitative reverse transcription polymerase chain reaction (RT-PCR). The relationship between ADAM17 mRNA expression level and clinicopathological features of HCC was evaluated.

Results: NHCC had lower differentiation and was more frequently of microvascular invasion (10/12) than SHCC (3/11) and SLHCC (3/8) (P<0.05), but no statistical difference was observed between SHCC and SLHCC comparing their clinicopathological features. ADAM17 mRNA expression was detected in 77.4% (24/31) of HCC tissues and was significantly higher than that in paired non-cancerous liver tissues in which only 35.5% (11/31) of the samples were detected of the expression (P<0.05). The expression of ADAM17 mRNA was much higher in NHCC than in SHCC and SLHCC (P<0.05), while no significant difference was discovered between SHCC and SLHCC. The quantities of ADAM17 mRNA were significantly higher in poorly differentiated HCC than in well or moderately differentiated HCC, but no statistical difference was found concerning liver cirrhosis, tumor capsule formation or microvascular invasion of the cancer.

Conclusion: The increased expression of ADAM17 may play a key role in the development of HCC. The expression levels of ADAM17 mRNA varied among different pathological types of HCC. Lower mRNA expression of ADAM17 mRNA in SLHCC may be associated with the better molecular pathological features of SLHCC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
ADAM17 transcription was detected in HCC but no obvious transcription was observed in paired non-cancerous tissues.
Figure 2
Figure 2
The expression of ADAM17 mRNA was higher in NHCC compared with SHCC and SLHCC.
Figure 3
Figure 3
Transcription level of ADAM17 in three groups of HCC.
See this image and copyright information in PMC

References

    1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533–543. - PubMed
    1. Yang LY, Huang GW. Surgical strategy of large hepatocellular carcinoma. Linchuang Waike Zazhi. 2001;9:4–5.
    1. Yang LY, Huang GW, Huang JH, Yang JQ, Lü XS, Han M. Surgical excision of 114 cases of large hepatocellular carinomas. Zhongguo Shiyong Waike Zazhi. 2002;22:353–355.
    1. Poon RT, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg. 2002;194:592–602. - PubMed
    1. Régimbeau JM, Farges O, Shen BY, Sauvanet A, Belghiti J. Is surgery for large hepatocellular carcinoma justified. J Hepatol. 1999;31:1062–1068. - PubMed

Publication types